Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion

International Journal of Cardiology

Volumn 70, Issue 2, 1999, Pages 165-170

  Fujita, Masatoshi ^a   Kihara, Yasuki ^a   Hasegawa, Koji ^a   Nohara, Ryuji ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Arteriogenesis; Collateral circulation; Dogs; Heparin

Indexed keywords

HEPARIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; HEART INFARCTION; HEPARINIZATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD FLOW VELOCITY; COLLATERAL CIRCULATION; CONSTRICTION, PATHOLOGIC; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOGS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; ULTRASONOGRAPHY, DOPPLER, DUPLEX; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0033620858     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00080-7     Document Type: Article

References (23)

1. Fujita M., Mikuniya A., Takahashi M., et al. Acceleration of coronary collateral development by heparin in conscious dogs. Jpn Circ J. 51:1987;395-402.
2. Unger E.F., Sheffield C.D., Epstein S.E. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol. 260:1991;H1625-H1634.
3. Carroll S.M., White F.C., Roth D.M., Bloor C.M. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation. 88:1993;198-207.
4. Uchida Y., Yanagisawa-Miwa A., Nakamura F., et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J. 130:1995;1182-1188.
5. Fujita M., Yamanishi K., Hirai T., Ohno A., Miwa K., Sasayama S. Comparative effect of heparin treatment with and without strenuous exercise on treadmill capacity in patients with stable effort angina. Am Heart J. 122:1991;453-457.
6. Factor S.M., Okun E.M., Kirk E.S. The histological lateral border of acute canine myocardial infarction: a function of microcirculation. Circ Res. 48:1981;640-649.
7. Schaper W., De Brabander M., Lewi P. DNA synthesis and mitosis in coronary collateral vessels of the dog. Circ Res. 28:1971;671-679.
8. Fujita M., McKown D.P., McKown M.D., Hartley J.W., Franklin D. Evaluation of coronary collateral development by regional myocardial function and reactive hyperaemia. Cardiovasc Res. 21:1987;377-384.
9. Fujita M., McKown D.P., McKown M.D., Franklin D. Changes in coronary flow following repeated brief coronary occlusion in the conscious dog. Heart Vessels. 2:1986;87-90.
10. Fujita M., Franklin D. Diurnal changes in coronary blood flow in conscious dogs. Circulation. 76:1987;488-491.
11. El-Tamimi H., Mansour M., Pepine C.J., Wargovich T.J., Chen H. Circadian variation in coronary tone in patients with stable angina, protective role of the endothelium. Circulation. 92:1995;3201-3205.
12. Scheel K.W., Galindez T.A., Cook B., Rodriquez R.J., Ingram L.A. Changes in coronary and collateral flows and adequacy of perfusion in the dog following one and three months of circumflex occlusion. Circ Res. 39:1976;654-658.
13. Fujita M., Yamanishi K., Araie E., Sasayama S., McKown D.P., Franklin D. Determinants of collateral development in a canine model with repeated coronary occlusion. Heart Vessels. 9:1994;292-299.
14. Rentrop K.P., Thornton J.C., Feit F., Buskirk M.V. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol. 61:1988;677-684.
15. Kumar S., Shahabuddin S., Haboubi N., et al. Angiogenesis factor from human myocardial infarcts. Lancet. 2:1983;364-368.
16. Fujita M., Ikemoto M., Kishishita M., et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 94:1996;610-613.
17. Gu J.W., Santiago D., Olowe Y., Weinberger J. Basic fibroblast growth factor as a biochemical marker of exercised-induced ischemia. Circulation. 95:1997;1165-1168.
18. Fujita M., Sasayama S., Asanoi H., Nakajima H., Sakai O., Ohno A. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation. 77:1988;1022-1029.
19. Ejiri M., Fujita M., Miwa K., et al. Effects of heparin treatment on collateral development and regional myocardial function in acute myocardial infarction. Am Heart J. 119:1990;248-253.
20. Quyyumi A.A., Diodati J.G., Lakatos E., Bonow R.O., Epstein S.E. Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol. 22:1993;635-641.
21. Melandri G., Semprini F., Cervi V., et al. Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: a double-blind, randomized, placebo-controlled trial. Circulation. 88:1993;2517-2523.
22. Fujita M., Sasayama S., Kato K., Takaori S. Prospective, randomized, placebo-controlled, double-blind multicenter study of exercise with enoxaparin pretreatment for stable-effort angina. Am Heart J. 129:1995;535-541.
23. Gagliardi J.A., Prado N.G., Marino J.C., Lederer S., Ramos A.O., Bertolasi C.A. Exercise training and heparin pretreatment in patients with coronary artery disease. Am Heart J. 132:1996;946-951.